Exhibit 99.1

 

Joint Filing Agreement

 

The undersigned hereby agree that the Statement on Schedule 13G dated January 15, 2025 with respect to the common stock, par value $0.001 per share, of INmune Bio Inc., and any amendments thereto executed by each and any of the undersigned shall be filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.

Praetorian PR LLC
 
By:

/s/ Harris Kupperman

  
  Harris Kupperman, Managing Member
Date: 01/15/2025

 

Praetorian Capital Fund LLC
 
By:

/s/ Harris Kupperman

  
  Harris Kupperman, Managing Member of its Manager
Date: 01/15/2025

 

Praetorian Capital Management LLC
 
By:

/s/ Harris Kupperman

  
  Harris Kupperman, Managing Member
Date: 01/15/2025

 

Mongolia (Barbados) Corp.
 
By:

/s/ Genevieve Walkden

  
  Genevieve Walkden, Chief Financial Officer
Date: 01/15/2025

 

Mongolia Growth Group Ltd.
 
By:

/s/ Harris Kupperman

  
  Harris Kupperman, CEO and Executive Chairman
Date: 01/15/2025

 

Kupperman Harris
 
By:

/s/ Harris Kupperman

  
  Harris Kupperman
Date: 01/15/2025

 

Grafico Azioni INmune Bio (NASDAQ:INMB)
Storico
Da Feb 2025 a Mar 2025 Clicca qui per i Grafici di INmune Bio
Grafico Azioni INmune Bio (NASDAQ:INMB)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di INmune Bio